A machine learning model for identifying patients at risk for wild-type transthyretin amyloid cardiomyopathy

Transthyretin amyloid cardiomyopathy, an often unrecognized cause of heart failure, is now treatable with a transthyretin stabilizer. It is therefore important to identify at-risk patients who can undergo targeted testing for earlier diagnosis and treatment, prior to the development of irreversible...

Descripción completa

Detalles Bibliográficos
Autores principales: Huda, Ahsan, Castaño, Adam, Niyogi, Anindita, Schumacher, Jennifer, Stewart, Michelle, Bruno, Marianna, Hu, Mo, Ahmad, Faraz S., Deo, Rahul C., Shah, Sanjiv J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113237/
https://www.ncbi.nlm.nih.gov/pubmed/33976166
http://dx.doi.org/10.1038/s41467-021-22876-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8113237/
https://www.ncbi.nlm.nih.gov/pubmed/33976166
http://dx.doi.org/10.1038/s41467-021-22876-9

Ejemplares similares